What does Ardelyx, Inc. do?

Jun 22 2025 06:42 PM IST
share
Share Via
Ardelyx, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for cardiorenal and gastrointestinal diseases. As of March 2025, it reported net sales of $74 million and a net loss of $41 million, with a market cap of approximately $849.36 million.
Overview:
Ardelyx, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for cardiorenal and gastrointestinal diseases, operating within the Pharmaceuticals & Biotechnology industry and classified as a small-cap company.

Financial Snapshot:
Most recent Net Sales: 74 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -41 Million (Quarterly Results - Mar 2025)
Market-cap: USD 849.36 Million (Small Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.42
Return on Equity: -36.79%
Price to Book: 5.83

Contact Details:
Address: 34175 Ardenwood Blvd, FREMONT CA: 94555-3653
Tel: 1 510 7457047
Fax: 1 510 7450493
Website: https://www.ardelyx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Ardelyx, Inc. Hits Day Low of $5.49 Amid Price Pressure
Sep 29 2025 02:12 PM IST
share
Share Via
Is Ardelyx, Inc. technically bullish or bearish?
Sep 20 2025 07:45 PM IST
share
Share Via
Is Ardelyx, Inc. overvalued or undervalued?
Sep 20 2025 06:20 PM IST
share
Share Via
Is Ardelyx, Inc. overvalued or undervalued?
Jun 25 2025 08:58 AM IST
share
Share Via